What exactly is Osurnia and why does it need three ingredients?

Osurnia is a gel-based otic suspension approved by the FDA Center for Veterinary Medicine under NADA 141-460 for treating otitis externa in dogs associated with susceptible bacteria and the yeast Malassezia pachydermatis (FDA, n.d.). It combines three active ingredients that each target a different piece of the infection: florfenicol, a broad-spectrum antibiotic, kills or suppresses bacteria such as Staphylococcus pseudintermedius; terbinafine hydrochloride, an antifungal, targets yeast overgrowth; and betamethasone acetate, a corticosteroid, reduces the swelling, redness, and itching that make the ear canal painful and narrowed in the first place.

This three-in-one design mirrors why chronic canine ear disease is so often multifactorial. Merck Veterinary Manual notes that otitis externa rarely has a single cause — it typically involves a combination of underlying triggers like allergies or moisture plus secondary bacterial or yeast invaders that take advantage of the inflamed environment (Merck Veterinary Manual, 2024). A product treating only the infection while leaving the swelling untreated, or vice versa, tends to produce incomplete or short-lived improvement, which is the rationale behind combination otic formulas like this one.

What symptoms make a vet reach for this particular ear medication?

Veterinarians typically prescribe Osurnia after examining ear canal debris under a microscope (cytology) and confirming both bacterial rods or cocci and Malassezia yeast are present, or when clinical signs strongly suggest a mixed infection. Common owner-reported signs include a persistent head shake or tilt, scratching at the ear, a dark brown or yellowish discharge, and a distinct yeasty or foul odor that the American Veterinary Medical Association lists among the hallmark signs pet owners should bring to a vet's attention (AVMA, n.d.).

Redness and swelling of the visible ear canal opening, pain when the base of the ear is touched, and crusting or thickened skin around the ear flap often accompany more advanced or chronic cases. Some dogs also show behavior changes such as reduced interest in play or irritability, which owners sometimes miss as ear-related until the vet points out how tender the canal is on exam.

How is Osurnia actually applied at the vet's office?

Unlike ear drops owners must administer at home daily, Osurnia's labeled protocol calls for exactly two doses given seven days apart, and both are typically applied by veterinary staff during in-clinic visits (FDA, n.d.). The single-dose tube delivers a gel that adheres to the ear canal lining rather than running out, which is the basis for the extended, week-long dosing interval compared to older twice-daily otic drop products.

Before each application, the ear canal is usually cleaned and dried, since debris and excess wax can block the gel from reaching the infected tissue. The applicator tip is inserted into the vertical canal, the dose is instilled, and the base of the ear is massaged briefly to help distribute it — a technique similar to what Merck Veterinary Manual describes as standard practice for any topical otic treatment to maximize contact with the affected epithelium (Merck Veterinary Manual, 2024).

What side effects or reactions should owners watch for?

Reported adverse effects from Osurnia in FDA field studies include transient signs at the application site such as erythema (redness), a mild odor, or a temporary increase in head shaking right after dosing, most of which resolved without intervention (FDA, n.d.). Because betamethasone is a corticosteroid, some dogs — particularly small or steroid-sensitive breeds — may show transient systemic effects like increased thirst, urination, or appetite in the days following treatment, effects that typically fade once the drug clears the system.

Owners should also know that corticosteroids can mask the early signs of a worsening infection by reducing pain and swelling even if the underlying bacteria or yeast persist. This is part of why the labeled recheck at day seven — before the second dose — matters: it lets the veterinarian confirm the ear is actually improving on exam and cytology, not just feeling less painful to the dog.

Which dogs should not receive this ear treatment?

The product label specifically warns against use in dogs with a known or suspected ruptured tympanic membrane (perforated eardrum), since corticosteroid and antibiotic components reaching the middle ear can cause additional irritation or, in some formulations, ototoxicity affecting hearing and balance (FDA, n.d.). Vets typically confirm the eardrum is intact via otoscopic exam before the first dose, which is one reason self-treating a dog's ear at home without a diagnosis is discouraged.

Dogs with known hypersensitivity to florfenicol, terbinafine, or corticosteroids, and those with deep ulcerative wounds in the canal, are also generally not candidates. Breeding, pregnant, or lactating dogs were not evaluated in FDA safety studies for this product, so veterinarians typically weigh alternative options for those patients (FDA, n.d.).

Does the ear infection need a recheck after the two doses are given?

Yes — the labeled protocol is built around a day-zero and day-seven visit, and many veterinarians also schedule a follow-up exam roughly two to four weeks after the second dose to confirm the infection has fully cleared, since visible improvement in odor and discharge doesn't always mean the canal has returned to normal on cytology (Merck Veterinary Manual, 2024). Persistent or recurring infections often signal an unaddressed underlying cause, most commonly an environmental or food allergy, that needs separate management to prevent the cycle from repeating.

Chronic, recurring ear infections are one of the more common secondary complications of canine atopic dermatitis, and the American Veterinary Medical Association notes that dogs with repeated ear infections should be evaluated for an underlying allergic or endocrine condition rather than treated indefinitely with topical antimicrobials alone (AVMA, n.d.).

How does this compare with daily ear drops or oral medication?

The main practical difference is dosing frequency and who administers it: traditional daily or twice-daily topical otic drops rely entirely on owner compliance at home over one to two weeks, while Osurnia's two-visit protocol shifts both applications to the clinic, which can improve consistency for owners who struggle to medicate a resistant or head-shy dog. This can matter clinically, since incomplete courses of topical antimicrobials are a recognized contributor to recurrent and resistant ear infections in dogs.

Oral antibiotics or antifungals are typically reserved for infections that have progressed to otitis media (middle ear) or are resistant to topical therapy, since Merck Veterinary Manual notes that most uncomplicated otitis externa responds well to appropriately chosen topical treatment without needing systemic drugs (Merck Veterinary Manual, 2024). Choosing between a topical combination product, ear cleaners alone, or systemic medication depends on culture results, canal anatomy, and how far the infection has progressed.